ภาควิชากุมารเวชศาสตร์ | คณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล

71.

Niyomnaitham S, Toh ZQ, Licciardi PV, Wongprompitak P, Srisutthisamphan K, Copeland KK, Chokephaibulkit K.

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
J Infect. 2022.

72.

Chantaratin S., Trimetha K., Werarak P., Lapphra K., Maleesatharn A., Rungmaitree S., Wittawatmongkol O., Phongsamart W., Kongstan N., Khumcha B., Chokephaibulkit K.

Depression and Anxiety in Youth and Young Adults Living with HIV: Frequency and Associated Factors in Thai Setting
Journal of the International Association of Providers of AIDS Care. 2022. 21

73.

Niyomnaitham S., Quan Toh Z., Wongprompitak P., Jansarikit L., Srisutthisamphan K., Sapsutthipas S., Jantraphakorn Y., Mingngamsup N., Licciardi P.V., Chokephaibulkit K.

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
Human Vaccines and Immunotherapeutics. 2022.

74.

Sirijatuphat R, Manosuthi W, Niyomnaitham S, Owen A, Copeland KK, Charoenpong L, Rattanasompattikul M, Mahasirimongkol S, Wichukchinda N, Chokephaibulkit K.

Early Treatment of Favipiravir in COVID-19 Patients Without Pneumonia: A Multicentre, Open-Labelled, Randomized Control Study
Emerging Microbes and Infections. 2022. 11 (1): 2197-2206.

75.

Apiwattanakul M., Suanprasert N., Rojana-Udomsart A., Termglinchan T., Sinthuwong C., Tantirittisak T., Hanchaiphiboolkul S., Angchaisuksiri P., Srimahachota S., Wongsawat J., Stiudomkajorn S., Kiertiburanakul S., Techasaensiri C., Laisuan W., Manosuthi W., Doungngern P., Jaroenkunathum W., Jivapaisarnpong T., Panjangampatthana A., Chimmanee J., Chokephaibulkit K.

Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations
PLoS One. 2022. 17 (8):

76.

Phongsamart W, Srifeungfung S, Chatsuwan T, Rungnobhakhun P, Maleesatharn A, Chokephaibulkit K.

Streptococcus pneumoniae Causing Invasive Diseases in Children and Adults in Central Thailand, 2012-2016
Vaccines. 2022. 10 (8):

77.

Niyomnaitham S, Chatsiricharoenkul S, Toh ZQ, Senawong S, Pheerapanyawaranun C, Phumiamorn S, Licciardi PV, Chokephaibulkit K.

Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study
Vaccines. 2022. 10 (9):

78.

Khanthathasiri S., Kriengsoontornkij W., Monsomboon A., Phongsamart W., Lapphra K., Wittawatmongkol O., Rungmaitree S., Chokephaibulkit K.

Outcomes of Single-Dose Empirical Antibiotic Treatment in Children With Suspected Sepsis Implemented in the Emergency Department
Pediatric Emergency Care. 2022. 38 (9): 426-430.

79.

Chatsiricharoenkul S., Niyomnaitham S., Posen H.J., Toh Z.Q., Licciardi P.V., Wongprompitak P., Duangchinda T., Pakchotanon P., Chantima W., Chokephaibulkit K.

Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
Frontiers in Immunology. 2022. 13

80.

Singtoroj T, Teeraananchai S, Chokephaibulkit K, Phanuphak N, Gatechompol S, Hansudewechakul R, Dang HLD, Tran DNH, Kerr SJ, Sohn A.

Factors associated with morbidity and mortality among sexually active Asian adolescents and young adults with perinatally acquired HIV
AIDS Res Hum Retroviruses. 2022.

ผลงานที่ได้รับการตีพิมพ์